Effect of vitamin B12 deficiency on otoacoustic emissions

por KARLI, R., GÜL, A., UĞUR, B.
Publicado 2013

Unified modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes

por Gul, A, Bozkurt, Y, Demir, A, Erman, B
Publicado 2015

Differential response to anakinra and adalimumab in a patient with DADA2 syndrome

por Toz, B, Erer, B, Kamali, S, Ocal, L, Gul, A
Publicado 2015

Novel coronavirus 2019 (COVID-19) pandemic outbreak: A comprehensive review of the current literature

por Ullah, H., Ullah, A., Gul, A., Mousavi, T., Khan, M.W.
Publicado 2021

Novel coronavirus 2019 (COVID-19) pandemic outbreak: A comprehensive review of the current literature

por Ullah, H., Ullah, A., Gul, A., Mousavi, T., Khan, M.W.
Publicado 2021

PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome

por Kasapcopur, O, Tugal-Tutkun, I, Barut, K, Erener-Ercan, T, Gul, A
Publicado 2013

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF

por Gul, A, Özdogan, H, Kasapcopur, O, Erer, B, Ugurlu, S, Sevgi, S, Turgay, S
Publicado 2015

PW01-015 – Canakinumab in adults with colchicin resistant FMF

por Gül, A, Özdoğan, H, Kasapçopur, Ö, Erer, B, Uğurlu, S, Davis, N, Sevgi, S
Publicado 2013

P01-020 – Starting time of inflammatory attacks in patients

por Berktaş, F, Alpay, N, Toz, B, Bakkaloğlu, OK, Erer, B, Gül, A
Publicado 2013

PW02-011 - Favorable response to anakinra in aisle patients

por Ozdogan, H, Gattorno, M, Ugurlu, S, Di Rocco, M, Hatemi, G, Ustek, D, Gul, A
Publicado 2013

Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic

por Khan, M., Tu-Zahra, F., Gul, A., Saleem, M.Z., Riaz, M., Gul, W.
Publicado 2022

PW03-010 - MHC complexity in Behçet's disease

por Ombrello, MJ, Kirino, Y, de Bakker, P, Cosan, F, Kastner, DL, Gul, A, Remmers, EF
Publicado 2013

Pathological and immunological features of autoinflammatory syndrome associated with lymphedema (AISLE)

por Gul, A, Ozdogan, H, Ugurlu, S, Kasapcopur, O, Buyukbabani, N, Emekli, U, Emrence, Z, Ustek, D
Publicado 2015

PW03-014 - TLR4 and MEFV variants are Behçet's risk factors

por Kirino, Y, Zhou, Q, Ishigatsubo, Y, Mizuki, N, Kim, Y, Kastner, DL, Gül, A, Remmers, EF
Publicado 2013

Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul – Turkey

por Toklu, Hale Z., Dülger, Gül A., Hıdıroğlu, Seyhan, Akici, Ahmet, Yetim, Aslıhan, Gannemoğlu, H. Mustafa, Güneş, Haşim
Publicado 2012

PReS-FINAL-2328: Developing and validating the new severity score for FMF

por Demirkaya, E, Acikel, C, Gul, A, Gattorno, M, Ben-Chetrit, E, Ozdogan, H, Hashkes, P, Polat, A, Livneh, A, Ozen, S
Publicado 2013

Identification of ERAP1 protein allotypes in the Turkish population and evaluation of their contributions to Behçet's disease risk

por Remmers, EF, Takeuchi, M, Ombrello, MJ, Kirino, Y, Erer, B, Tugal-Tutkun, I, Seyahi, E, Ozyazgan, Y, Gul, A, Kastner, DL
Publicado 2015

CECR1 p.Gly47Arg mutations are not increased in frequency in Turkish Behçet's disease patients compared with healthy controls

por Erer, B, Remmers, E, Takeuchi, M, Ustek, D, Tugal-Tutkun, I, Seyahi, E, Ozyazgan, Y, Gul, A, Ombrello, M, Kastner, D
Publicado 2015

PW01-028 – Developing a new severity score for FMF

por Demirkaya, E, Acikel, C, Gul, A, Gattorno, M, Ben-Chetrit, E, Ozdogan, H, Hashkes, P, Polat, A, Karadag, O, Livneh, A, Ozen, S
Publicado 2013

Flavonoids and Their Biological Secrets

por Rashid, M. I., Fareed, M. I., Rashid, H., Aziz, H., Ehsan, N., Khalid, S., Ghaffar, I., Ali, R., Gul, A., Hakeem, Khalid Rehman
Publicado 2019